Patients with multiple myeloma treated with idecabtagene vicleucel, known as “ide-cel,” a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according to a study published in Blood Advances.
Radiometer celebrates 70 years in acute care diagnostics
In 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio
July 1, 2024